The U.S. Food and Drug Administration has issued a complete response letter for Aquestive Therapeutics' oral film drug designed to treat severe allergic reactions, the company announced Monday, delaying a potential new option for millions at risk.
After a prolonged period of U.S. dominance, international equities are staging a comeback. Analysts point to shifting fundamentals, attractive valuations, and a weakening dollar as tailwinds for emerging markets, with one Vanguard ETF positioned at the center of this transition.
Former President Donald Trump has announced Kevin Warsh, a former Federal Reserve governor and economic advisor, as his pick to lead the central bank. The nomination comes as incumbent Chair Jerome Powell faces a federal investigation related to his congressional testimony.
Amazon's recent workforce reductions, bringing total corporate cuts to 30,000, reflect a broader shift in how layoffs are perceived. No longer framed as a sign of failure, they are increasingly presented as a strategic, forward-looking move to streamline operations and focus on priorities like AI, a narrative that resonates with investors despite the human impact.
Amgen has transferred full rights for the atopic dermatitis drug rocatinlimab back to Kyowa Kirin, clearing the path for the Japanese firm to pursue US approval by 2026. The move comes despite the drug meeting all trial endpoints, reflecting Amgen's portfolio reprioritization and a tempered market outlook for the OX40 inhibitor class.
A stark consensus is emerging among prediction market traders and analysts, with a 71% probability now priced in for Bitcoin to fall below $65,000 within two years. This bearish outlook follows a weekend sell-off to nine-month lows and is supported by underwater ETF positions, technical warnings, and concerns over a sustained market downturn rather than a temporary correction.
South Korean financial regulators are deploying advanced artificial intelligence to monitor cryptocurrency transactions in real-time, aiming to detect and preempt market manipulation. The move, part of a broader crackdown, could see violators face severe penalties, including life imprisonment.
As the housing market evolves, a three-digit number remains the decisive factor for mortgage seekers. The latest FICO scoring model now considers rental history, potentially opening doors for millions of aspiring homeowners.
A landmark tripartite agreement between financial heavyweight Schroders, battery leader CATL, and investment firm Lochpine Capital aims to deploy up to 10GWh of energy storage across Europe, marking a significant step in the continent's clean energy transition.
As mortgage rates fluctuate and ambitious policy ideas emerge, economists warn that financing tweaks cannot solve the core issue: a chronic shortage of homes.
Hong Kong apparel giant Crystal International is investing in a high-tech logistics center in China, aiming to slash fabric transfer times by 75% and power operations with solar energy as part of its broader smart manufacturing push.
Insurance brokerage giant Brown & Brown sees a key price target cut to $81 following its fourth-quarter earnings, which revealed robust fee growth but concerns over slowing organic revenue expansion.
CIBC lowers OpenText's price target to $37, citing softer guidance and a watchful stance on the company's planned divestiture of non-core assets to sharpen its AI focus.
Warren Buffett once admitted that managing a smaller pool of capital can be a 'huge structural advantage.' For retail investors, this isn't just theory—it's a practical edge in accessing high-growth opportunities that are now out of reach for the investing giant.
As the U.S. Treasury prepares its quarterly debt issuance update, bond dealers are on high alert for any shift in strategy aimed at managing soaring yields. While major changes are seen as unlikely, the administration's broader financial interventions have markets questioning the long-held "regular and predictable" borrowing mantra.
A provocative analysis suggests the widespread adoption of GLP-1 drugs like Ozempic and Wegovy could trim airline fuel bills by reducing passenger weight, potentially passing savings to travelers. But industry experts debate whether the math adds up.
While a recent executive order aims to streamline AI rules, experts caution that customer experience teams face a complex transition—not a regulatory holiday—demanding stronger internal governance.
A sharp sell-off in gold and silver, alongside falling oil prices, has sparked volatility across global markets at the start of a week packed with major earnings and central bank decisions.
Eli Lilly's CEO sees Medicare's new policy covering obesity treatments as a pivotal moment, poised to unlock access for millions of beneficiaries to its incoming oral drug, orforglipron, and intensify the market battle with Novo Nordisk.
Amid a mixed market landscape, corporate insiders are placing significant bets on select small-cap stocks. We analyze three companies where recent insider buying and strategic moves signal potential value, despite broader economic headwinds.
